EP3880670
Bætt efnasmíði á lykil-milliefni fyrir KRAS G12C hindraefnasamband
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.11.2019EP published:
7.6.2023EP application number:
19820938.9
EP translation filed:
16.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
14.11.2039Expiry date:
14.11.2026Next due date:
30.11.2026
Title in English:
IMPROVED SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUNDLanguage of the patent:
English
Timeline
Today
15.11.2019EP application
7.6.2023EP Publication
16.8.2023Translation submitted
15.9.2023Registration published
14.11.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320, US
Inventor
Name:
PARSONS, Andrew ThomasAddress:
Thousand Oaks, California 91320-1799, US
Name:
COCHRAN, Brian McNeilAddress:
Thousand Oaks, California 91320-1799, US
Name:
POWAZINIK, IV, WilliamAddress:
Thousand Oaks, California 91320-1799, US
Name:
CAPORINI, Marc AnthonyAddress:
Thousand Oaks, California 91320-1799, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862768802 PDate:
16.11.2018Country:
US
Classification
Categories:
C07D 401/04, C07D 401/14
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 24.11.2023
Expires: 14.11.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 25.10.2024
Expires: 14.11.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.11.2025
Expires: 14.11.2026
Payer: Árnason Faktor ehf.